FDA Moves To Settle NAC’s Long, Strange Supplement Status
Published Date: 11/17/2026
Proposed Rule
Summary
The FDA wants to officially say that N-acetyl-L-cysteine (NAC) can be sold as a dietary supplement. This means companies can legally put NAC in their products without breaking the rules, as long as they follow other laws. People and businesses making or selling supplements with NAC should share their thoughts by January 19, 2027.
Analyzed Economic Effects
4 provisions identified: 2 benefits, 2 costs, 0 mixed.
NAC can be sold as dietary supplements
If finalized, FDA would place N-acetyl-L-cysteine (NAC) on a regulation (proposed §190.1(a)) confirming NAC is not excluded from the statutory dietary supplement definition and that adding NAC to a dietary supplement is not a prohibited act under section 301(ll) of the FD&C Act. That means products containing NAC could be lawfully marketed as dietary supplements so long as they otherwise meet the dietary supplement definition and are not otherwise in violation of the FD&C Act.
Small compliance reading costs for industry
FDA estimates the rule's primary annualized industry compliance costs (for reading and understanding the rule) are about $99 per year at a 3% discount rate and $121 per year at a 7% discount rate, with a present value of total costs of approximately $848 when annualized over 10 years. FDA states the market has few firms operating in the NAC market, so these impacts are small.
FDA found minimal safety concerns for oral NAC
FDA's systematic review identified 41 high-confidence studies of orally administered NAC and concluded a "minimal" Level of Concern for adverse events. Studies included doses up to 9,000 mg per day and durations up to 3 years; commonly labeled dietary supplement servings overlap with study doses (e.g., 600 mg, 1,000 mg, 1,200 mg per day).
NAC supplements must meet dietary supplement rules
If NAC is allowed as a dietary supplement, NAC-containing products would be subject to all requirements that apply to dietary supplements under the FD&C Act and FDA implementing regulations (for example, current Good Manufacturing Practice requirements at 21 CFR part 111). FDA states any adulterated or misbranded dietary supplement may be subject to compliance or enforcement action.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-20848, Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods
The FDA is changing food rules to allow salt substitutes in many standardized foods, helping companies make lower-sodium options. This move aims to cut heart disease risks by reducing sodium without changing how foods basically taste or look. The new rule kicks in December 14, 2026, and food makers have until November 12, 2026, to raise any concerns, with no big costs expected.
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2025-04978, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA is delaying a new rule about nonprescription drugs that have extra conditions for use. Originally set to start on March 21, 2025, the rule’s start date is now pushed back to May 27, 2025, to allow more time for review. This affects drug makers and consumers by giving everyone extra time to prepare for the new requirements without any immediate cost changes.
2025-01840, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA’s new rule about nonprescription drugs needing extra conditions before use was set to start on January 27, 2025, but it’s now delayed until March 21, 2025. This delay follows a presidential order to pause and review new rules before they take effect. Drug makers, sellers, and consumers should note the new start date and get ready for the updated rules soon.
Previous / Next Documents
Previous: 2026-23342, Advisory Committee on Reactor Safeguards Functions
The Nuclear Regulatory Commission wants to shrink the Advisory Committee on Reactor Safeguards to just the essential members and tasks needed by law. This change affects the committee’s size and duties, aiming to streamline how nuclear safety advice is given. People can share their thoughts on this plan until December 17, 2026, with no direct cost changes announced.
Next: 2026-23363, Periodic Reporting
The Postal Service wants to update how it measures Priority Mail by switching to a newer, more complete data source called PTR instead of the old ODIS-RPW system. This change won’t alter the basic way costs are calculated but aims to improve accuracy. If you’re involved with postal pricing or mail services, keep an eye out—comments on this update are due by November 27, 2026.